48,438 Shares in Maximus, Inc. $MMS Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company purchased a new position in Maximus, Inc. (NYSE:MMS) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 48,438 shares of the health services provider’s stock, valued at approximately $2,604,000. The Manufacturers Life Insurance Company owned about 0.09% of Maximus at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Maximus during the 2nd quarter valued at about $400,186,000. Dimensional Fund Advisors LP grew its holdings in Maximus by 7.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider’s stock valued at $135,084,000 after purchasing an additional 141,362 shares during the period. Reinhart Partners LLC. grew its holdings in Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock valued at $106,575,000 after purchasing an additional 1,127,346 shares during the period. Geode Capital Management LLC increased its position in Maximus by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock worth $127,952,000 after purchasing an additional 5,130 shares during the last quarter. Finally, Van Berkom & Associates Inc. increased its position in Maximus by 3.7% during the first quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider’s stock worth $75,137,000 after purchasing an additional 41,862 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Up 0.1%

Shares of NYSE:MMS opened at $57.67 on Thursday. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. Maximus, Inc. has a 1 year low of $52.73 and a 1 year high of $100.00. The stock has a market capitalization of $3.02 billion, a P/E ratio of 8.52 and a beta of 0.59. The stock has a 50-day simple moving average of $57.78 and a 200-day simple moving average of $63.16.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, beating the consensus estimate of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus’s revenue for the quarter was down 5.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities analysts forecast that Maximus, Inc. will post 8.03 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Friday, August 14th. Maximus’s dividend payout ratio (DPR) is currently 19.50%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on MMS shares. Zacks Research lowered shares of Maximus from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a report on Monday, August 17th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.